Logo 1 Logo 2

Clinical Trial Details

Trial ID: L2310
Source ID: NCT01387165
Associated Drug: Treatment
Title: Epidemiologic Survey to Describe the Current Medical Practice of General Practitioners Treating Subjects With Type 2 Diabetes Mellitus in Latina
Acronym: DEAL
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG: Treatment
Outcome Measures: Primary: The achievement of the planned completed number of questionnaires., up to 1 year | Secondary: Changes in glycemic parameters in accordance with the historical information provided by the GPs and her/his judgement of control based on that information., up to 1 year|Proportion of subjects who respond to any given treatment applied through the level of HbA1c responders (defined as subjects who have achieved HbA1c <7%), up to 1 year|Assessment of total cholesterol, up to 1 year|Assessment of free fatty acids, up to 1 year|Assessment of high-density lipoprotein, up to 1 year|Assessment low-density lipoprotein, up to 1 year|Assessment of triglycerides, up to 1 year|Assessment of LDL relative flotation, up to 1 year|Assessment of total cholesterol/HDL ratio, up to 1 year|Assessment of LDL/HDL ratio, up to 1 year|Assessment of fasting blood glucose, up to 1 year
Sponsor/Collaborators: Sponsor: GlaxoSmithKline
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases:
Enrollment: 3592
Study Type: OBSERVATIONAL
Study Designs: Observational Model: |Time Perspective: p
Start Date: 2004-10
Completion Date: 2005-10
Results First Posted:
Last Update Posted: 2017-06-08
Locations:
URL: https://clinicaltrials.gov/show/NCT01387165